Login / Signup

COVID-19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies.

Jozefien DeclercqEls TobbackStijn VanheeNatalie De RuyckSarah GerloPhilippe GevaertLinos Vandekerckhove
Published in: Allergy (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • dengue virus
  • human health
  • risk assessment